Pharmacokinetics of soy-derived lysophosphatidylcholine compared with that of glycerophosphocholine: a randomized controlled trial
Bioscience, Biotechnology, and Biochemistry · 2024
DOI: 10.1093/bbb/zbae031 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Bioscience, Biotechnology, and Biochemistry, 2024. Verfasst von Ryohei Tanaka-Kanegae und 2 weiteren Autor:innen. Beteiligte Einrichtung: Sa ga Nutraceuticals Research Institute, Otsuka Pharmaceutical Co., Ltd., Saga, Japan. Hauptthemen laut MEDLINE: Lysophosphatidylcholines, Glycerylphosphorylcholine, Choline, Glycine max. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Otsuka Pharmaceutical Co., Ltd..
Abstract (Originalsprache)
Lysophosphatidylcholine (LPC) is present in various foods and contains a choline moiety such as in glycerophosphocholine (GPC). However, the potential of LPC as a choline source remains unclear. This study investigated the single-dose pharmacokinetics of 480 mg soy-derived LPC in 12 healthy men compared with that of either soy oil with the same lipid amount (placebo) or GPC with the same choline amount. Both LPC and GPC supplementation increased plasma choline, serum phospholipid, and serum triglyceride concentrations, but neither of them significantly elevated plasma trimethylamine N-oxide concentration. In addition, although the intake of LPC slightly increased plasma LPC16:0, LPC18:2, and total LPC concentrations, their concentrations remained within physiological ranges. No adverse events were attributed to the LPC supplementation. To the best of our knowledge, this study is the first to compare LPC and GPC pharmacokinetics in humans and shows that LPC can be a source of choline.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sa ga Nutraceuticals Research Institute, Otsuka Pharmaceutical Co., Ltd., Saga, Japan.
ORCID-Profile: Ryohei Tanaka-Kanegae
Förderung
- Otsuka Pharmaceutical Co., Ltd.
Zitieren
APA
Tanaka-Kanegae, R., Kimura, H., & Hamada, K. (2024). Pharmacokinetics of soy-derived lysophosphatidylcholine compared with that of glycerophosphocholine: a randomized controlled trial. Bioscience, Biotechnology, and Biochemistry. https://doi.org/10.1093/bbb/zbae031
Vancouver
Tanaka-Kanegae R, Kimura H, Hamada K. Pharmacokinetics of soy-derived lysophosphatidylcholine compared with that of glycerophosphocholine: a randomized controlled trial. Bioscience, Biotechnology, and Biochemistry. 2024. doi:10.1093/bbb/zbae031
BibTeX
@article{TanakaKanegae2024,
author = {Tanaka-Kanegae, Ryohei and Kimura, Hiroyuki and Hamada, Koichiro},
title = {Pharmacokinetics of soy-derived lysophosphatidylcholine compared with that of glycerophosphocholine: a randomized controlled trial},
journal = {Bioscience, Biotechnology, and Biochemistry},
year = {2024},
doi = {10.1093/bbb/zbae031}
}
EUVIMED